Dr. Abdulqader Al Khayat, Executive Director of DuBiotech and executives from TECOM Investments including Abdullatif Al Mulla, CEO and George Mushahwar, COO, attended the groundbreaking ceremony.
The laboratory complex will be complete by December 2007 followed by the headquarters in September 2008.
Browse
related articles
DuBiotech begins construction on USD400 million biotechnology cluster
- United Arab Emirates: Thursday, July 13 - 2006 at 14:00
- PRESS RELEASE
Related content
The Dubai Biotechnology and Research Park (DuBiotech), earlier this week, broke ground on the first phase of its USD400 million (AED 1.47 billion) biotechnology industry cluster which will include its laboratory complex and headquarters.
DuBiotech headquarters.
Article Options
Log in to request more information from DuBiotech
Posted by Anne-Birte Stensgaard, Senior News EditorThursday, July 13 - 2006 at 14:00 UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of AME Info FZ LLC / Emap Limited.
This article was updated on Wed Mar 28 2007.
Notes and Media Contacts »
Caption for 'DuBiotech groundbreaking': Abdullatif Al Mulla, CEO of TECOM Investments, George Mushahwar, COO of TECOM Investments, Dr. Abdulqader Al Khayat, Executive Director of DuBiotech with members of the DuBiotech team at the groundbreaking ceremony.
About Dubai Biotechnology and Research Park (DuBiotech)
Announced in February 2005, the Dubai Biotechnology and Research Park (DuBiotech) is creating a science and business park dedicated to the biotechnology industry. DuBiotech has two main initiatives. The first is the Foundation for Research and Innovation (FRI), which will be its main arm, focusing on government-funded R&D. The FRI will initially focus on medical research and genetics, plant biotechnology encompassing food and agricultural biotech, environmental biotech, equine-related biotechnology, drug discovery, stem cell research, infectious diseases, and forensic research. The second arm of DuBiotech aims to set up a biotechnology industry cluster with the appropriate infrastructure, facilities and services for incubators, R&D labs, biotech-related educational institutions, suppliers, biotech-related manufacturing companies and organisations from other sectors in the industry.
For further information, please contact:
Baiju Francis
Account Manager
JIWIN
The Public Relations Arm of Dubai Press Club
T:+9714 361 3 596
F:+9714 368 8 001
M:+97150 7971996
About Dubai Biotechnology and Research Park (DuBiotech)
Announced in February 2005, the Dubai Biotechnology and Research Park (DuBiotech) is creating a science and business park dedicated to the biotechnology industry. DuBiotech has two main initiatives. The first is the Foundation for Research and Innovation (FRI), which will be its main arm, focusing on government-funded R&D. The FRI will initially focus on medical research and genetics, plant biotechnology encompassing food and agricultural biotech, environmental biotech, equine-related biotechnology, drug discovery, stem cell research, infectious diseases, and forensic research. The second arm of DuBiotech aims to set up a biotechnology industry cluster with the appropriate infrastructure, facilities and services for incubators, R&D labs, biotech-related educational institutions, suppliers, biotech-related manufacturing companies and organisations from other sectors in the industry.
For further information, please contact:
Baiju Francis
Account Manager
JIWIN
The Public Relations Arm of Dubai Press Club
T:+9714 361 3 596
F:+9714 368 8 001
M:+97150 7971996
Disclaimer »
Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com
Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.
For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions
